Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer.


Journal

Journal of geriatric oncology
ISSN: 1879-4076
Titre abrégé: J Geriatr Oncol
Pays: Netherlands
ID NLM: 101534770

Informations de publication

Date de publication:
05 2020
Historique:
received: 07 08 2019
revised: 30 10 2019
accepted: 16 12 2019
pubmed: 31 12 2019
medline: 29 7 2021
entrez: 30 12 2019
Statut: ppublish

Résumé

Older adults are underrepresented in landmark trials that determine treatment guidelines for pancreatic cancer. We used the National Cancer Database (NCDB) to compare treatment patterns and outcomes in stage I-III pancreatic cancer between older adult patients, defined as age 80 or older, to patients younger than 80. We identified 140,678 patients in the NCDB diagnosed with pancreatic cancer from 2004 to 2015. Patients with metastatic disease or non-adenocarcinoma histologies were excluded. Descriptive statistics comparing patients age 80+ and age <80 were generated. Logistic regression was used to evaluate predictors of cancer-directed therapy receipt (defined as receipt of chemotherapy, radiation, or surgery) in older patients, and Cox proportional hazards modeling was performed to evaluate survival in the older cohort. We identified 140,678 patients with non-metastatic pancreatic cancer, of which 23,395 patients (16.6%) were 80 or older. Among older patients, 44.5% of patients received cancer-directed therapy compared to 78.7% among other patients (p < .001). Older patients had worse 2-year survival at 11.3% versus 27.5% for younger (p < .001). 2-year survivorship decreased further in older patients who received no cancer-directed treatment, at 4.7% compared with 19.5% for older patients receiving treatment (p < .001). After propensity score matching, cancer-directed treatment remained associated with improved survival for older patients (hazard ratio 0.42; 95% confidence interval 0.41-0.43; p < .001). Rates of cancer-directed therapy were low in patients age 80+, with 55.5% receiving no therapy. Cancer-directed treatment was associated with an overall survival benefit. Future trials are needed to define optimal treatment paradigms in this population.

Identifiants

pubmed: 31883970
pii: S1879-4068(19)30368-6
doi: 10.1016/j.jgo.2019.12.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

652-659

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest We have no conflicts of interest to declare.

Auteurs

Richard Li (R)

Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

Jessica Vazquez (J)

Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

Jennifer Novak (J)

Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

Mina Sedrak (M)

Department of Medical Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

Susanne Warner (S)

Department of Surgical Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

Scott Glaser (S)

Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

Yi-Jen Chen (YJ)

Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA, United States of America.

William Dale (W)

Department of Supportive Care Medicine, City of Hope Medical Center, Duarte, CA, United States of America.

Arya Amini (A)

Department of Radiation Oncology, City of Hope Medical Center, Duarte, CA, United States of America. Electronic address: aamini@coh.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH